About Careers MedBlog Contact us

PCB Conducts Anti-doping Tests for Shoaib, Asif

by VR Sreeraman on August 1, 2007 at 8:28 PM
Font : A-A+

PCB Conducts Anti-doping Tests for Shoaib, Asif

Pakistani fast bowlers Shoaib Akhtar and Mohammad Asif, have undergone fresh doping tests ahead of the Twenty20 World Cup to be played in South Africa in September.

According to a spokesman for the Pakistan Cricket Board (PCB), the board has carried out doping tests on the 30 players shortlisted for the inaugural World Cup of the shortest version of the game.


"All the 30 players announced for the Twenty20 World Cup have been tested with the exception of Younis Khan, Yasir Arafat and Danish Kaneria who are playing county in England," the Daily Times quoted the spokesman, as saying.

The doping tests assume significance as both Shoaib and Asif were tested positive for taking banned steroid nandrolone in September last year before the ICC Champions Trophy in India.

The bowling due were initially banned by a PCB drugs inquiry panel, but then cleared by an appeals committee. Later in December, the World Anti-Doping Agency (WADA) challenged the decision in the Court of Arbitration for Sports (CAS).

But on July 2 this year, the CAS ruling that it has no jurisdiction to take up the appeal filed by the WADA, saying the plea was "inadmissible," as there is no specific agreement between the parties to allow it to rule on the merits of this particular dispute.

Source: ANI


Recommended Reading

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

PCB Conducts Anti-doping Tests for Shoaib, Asif Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests